Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms

Archives of Gynecology and Obstetrics

Volumn 284, Issue 2, 2011, Pages 411-419

  Virojchaiwong, Phongthorn ^a   Suvithayasiri, Visut ^a   Itharat, Arunporn ^b  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Menopausal symptoms; Modified Green climacteric scale; Pueraria mirifica

Indexed keywords

PLANT MEDICINAL PRODUCT;

ADULT; ARTICLE; CLIMACTERIUM; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DYSPEPSIA; ESTROGEN DEFICIENCY; EVENING DOSAGE; FEMALE; GREEN CLIMACTERIC SCALE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; LABORATORY TEST; MAJOR CLINICAL STUDY; MASTALGIA; MENOPAUSAL SYNDROME; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PUERARIA; PUERARIA MIRIFICA; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; TREATMENT DURATION; VASOMOTOR DISORDER;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYSTERECTOMY; MENOPAUSE; MIDDLE AGED; PHYTOESTROGENS; PHYTOTHERAPY; PLANT PREPARATIONS; PUERARIA; SEVERITY OF ILLNESS INDEX;

EID: 80052330099     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1689-5     Document Type: Article

References (34)

1. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA (2010) Premature menopause or early menopause: long-term health consequences. Maturitas 65(2):161-166
2. North American Menopause Society (2007) Menopause practice: a clinician's guide, 3rd ed. Cleveland, OH, North American Menopause Society, pp 9-18
3. Santoro N (2008) Symptoms of menopause: hot Flushes. evidence- based approach to menopause. Clin Obstet Gynecol 51:539-548
4. Knight DC, Eden JA (1996) A review of the clinical effects of phytoestrogens. Obstet Gynecol 87(5):897-904 (Pubitemid 26127148)
5. Dewicks PM (1995) Isoflavonoids. In: Harborne JB (ed) The flavonoid. Dhapman & Hall, London, pp 117-238
6. Lamlertkittikul S, Chandeying V (2004) Effectiveness and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: phase II study. J Med Assoc Thai 87:33-40 (Pubitemid 38314035)
7. Sukavaj T (1949) Herbal medicine. Thai J Med Sci 3:104-110
8. Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W, Malaivijitnond S (2007) Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas 56:322-331 (Pubitemid 46241761)
9. Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S (2008) Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas 59:137-148
10. Cherdshewasart W, Traosup V, Picha P (2008) Determination of the estrogenic activity of wild phytoestrogen-rich Pueraria mirifica MCF-7 proliferation assay. J Reprod Dev 4:63-67 (Pubitemid 351413900)
11. Chandeying V, Lamlertkittikul S (2007) Challenges in the conduct of Thai herbal scientific study: effectiveness and safety of phytoestrogen, Pueraria mirifica (Kwao Kuer Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women. J Med Assoc Thai 90:1274-1280 (Pubitemid 47414496)
12. Chandeying V, Sangthawan M (2007) Effectiveness comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study. J Med Assoc Thai 90:1720-1726 (Pubitemid 350057127)
13. Speroff L, Fritz MA (2005) Clinical gynecologic endocrinology and infertility, 7th edn. Williams & Wilkins, Philadelphia, Lippincott, pp 689-777
14. Smitasiri Y, Junyatum U, Songjitsawad A, Sripromma P, Trisrisilp S, Anuntalabhochai S (1986) Postcoital antifertility effects of Pueraria mirifica in rats. J Sci Fac Chiang Mai Univ 13:19-28
15. MacLennan A (1996) Symptoms and signs of the climacteric. In: Wren BG, Nachtigall LE (eds) Clinical management of the menopause. McGraw-Hill, Roseville, pp 7-15
16. Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H, Theppisai U (2008) Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause 15:530-535 (Pubitemid 351656760)
17. Ettinger B (2005) Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. Am J Med 118 (Suppl 12B):74-8
18. Coope J, Thomson JM, Poller L (1975) Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. Br Med J 4:139-143
19. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979) Estrogen therapy for severe persistent depression women. Arch Gen Psychiatry 36(5):550-554 (Pubitemid 9201186)
20. Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65(12 Pt 2): S147-S151
21. Wang KC, Lin YF, Qin CH, Chen TL, Chen CH (2010) Bisphenol - A interferes with estradiol-mediated protection in osteoarthritic chondrocytes. Toxicol Lett 5; 198(2):127-133
22. Maltais ML, Desroches J, Dionne IJ (2009) Changes in muscle mass and strength after menopause. J Musculoskelet Neuronal Interact 9(4):186-197
23. Thomas TN, Rhodin JA, Clark L, Garces A, Bryant M (2003) A comparison of the anti-inflammatory activities of conjugated estrogens and 17-beta estradiol. Inflamm Res 52(11):452-460 (Pubitemid 37449389)
24. Dijsselbloem N, Vanden BW, De NA, Haegeman G (2004) Soy isoflavones phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 15; 68(6):1171-1185 (Pubitemid 39094283)
25. Felson DT, Nevitt MC (1998) The effects of estrogen on osteoarthritis. Curr Opin Rheumatol 10(3):269-272 (Pubitemid 28286820)
26. Sarrel PM (1990) Sexuality and menopause. Obstet Gynecol 75(4Suppl):26S-30S; discussion 31S-35S (Pubitemid 20120737)
27. Kicovic PM, Cortes-Prieto J, Milojevic S, Haspels AA, Aljinovic A (1980) The treatment of postmenopause vaginal atrophy with Ovestin vaginal cream or suppositories: clinical endocrinological and safety aspects. Maturitas 14:23-31
28. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K (2003) Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 101(2):337-345 (Pubitemid 36170136)
29. Faure ED, Chantre P, Mares P (2002) Effects of a standardized soy extract on hot flushes: a multicenter double-blind, randomized, placebo-controlled study. Menopause 9(5):329-334 (Pubitemid 36701892)
30. Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC (2005) Oestrogen and progestogen hormone replacement therapy for perimenopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews, Issue 3. Art. no.: CD001018. doi:10.1002/14651858
31. Sanchanta P, Saenphet K, Saenphet S, Aritajat S, Wongsawad C (2005) Toxicological study of aqueous and ethanolic extracts from Pueraria mirifica Airy Shaw and Suvatabandhu on male rats. In: Brovelli E, Chansakaow S, Farias D et al (eds) III WOCMAP congress on medicinal and aromatic plants - volume 5: quality, effectiveness, safety, processing and trade in medicinal and aromatic plants. International Society for Horticultural Science, Leuven, Belgium
32. Egeland GM, Kuller LH, Matthews KA, Kelsey SF, Cauley J, Guzick D (1990) Hormone replacement therapy and lipoprotein changes during early menopause. Obstet Gynecol Nov 76(5 pt 1): 776-782 (Pubitemid 20353918)
33. Godsland IF (2001) Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 75:898-915 (Pubitemid 32401667)
34. Irwig L, Glaszious P, Wilson A, Macaskill P (1991) Estimating an individual's true cholesterol level and response to intervention. JAMA 266:1678-1685